Kenvue (KVUE) Q2 2025 10-Q Quarterly Report
Filed: Aug 7, 2025Period ending Jun 29, 2025
Health Care
Perfumes, Cosmetics & Other Toilet PreparationsSEC EDGAR Kenvue (KVUE) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 7, 2025 for the fiscal period ending Jun 29, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Kenvue Q2 2025 10-Q Analysis
Risk Factors
- • New strategic review risk triggered by July 2025 Board-initiated comprehensive review of alternatives including brand portfolio optimization
- • Strategic review process risk: potential delays, distractions, increased costs possibly harming business and stock price volatility
Kenvue Q2 2025 Quarterly FinancialsXBRL
Revenue
$3.8B
▼ -4.0% YoY▲ +2.6% QoQ
Net Income
$420M
▲ +624.1% YoY▲ +30.4% QoQ
Net Margin
10.9%
▲ +949bp YoY▲ +233bp QoQ
Source: XBRL data from Kenvue Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Kenvue Quarterly Reports
Get deeper insights on Kenvue
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.